IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. (12th June 2019)

• Record Type: Journal Article
• Authors: Rusconi, C.; Tucker, D.; Bernard, S.; Muzi, C.; Crucitti, L.; Stefani, P.; Cox, M.; Gini, G.; Re, A.; Sciarra, R.; Liberati, A.; Morello, L.; Arcari, A.; Mannina, D.; Vitagliano, O.; Sartori, R.; Chiappella, A.; Balzarotti, M.; Vitolo, U.; Thieblemont, C.; Rule, S.; Visco, C.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 244
• Page End: 245
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.54_2630
• Languages: English
• ISSNs: 0278-0232